Answer
Patients with symptomatic skin and subcutaneous tissue disorders should be carefully monitored during Nerlynx (neratinib maleate) treatment.
Sources for this answer
- Nerlynx 40 mg film-coated tabletsPierre Fabre Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated
Sources checked